Introduction
============

High-throughput RNA structure probing by means of selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) technology was first described in 2005.[@R1] SHAPE has revolutionized the analysis of structured RNA molecules. This technology allows one to determine the reactivity of nearly all nucleotides (nts) in a lengthy RNA molecule such as the 9 kb HIV-1 genome.[@R2] The SHAPE reactivities provide information on RNA structure: regions with low reactivity signify domains with substantial base paired RNA secondary structure and high SHAPE reactivity marks regions with largely unstructured nts.[@R1]^-^[@R5] The availability of detailed RNA structure information is important for addressing the biological function of small RNA domains or complete RNA molecules. In particular, the genomes of certain RNA viruses have been proposed to adopt a genome-scale ordered RNA structure (GORS) that is critical for virus replication, e.g., to resist the action of intracellular RNases or to allow the melting of double-stranded RNA replication intermediates.[@R6]^,^[@R7] This aspect has not yet been studied for the RNA genome of retroviruses like the human immunodeficiency virus type 1 (HIV-1).

RNA structure information is also important for certain applications. For instance, antiviral gene therapy based on the mechanism of RNA interference (RNAi) uses short hairpin RNA (shRNA) inhibitors that target the viral RNA genome.[@R8]^,^[@R9] We previously demonstrated that RNAi attack is influenced by the local RNA structure of the HIV-1 RNA target sequence[@R10]^,^[@R11] and more recently reported that the design of shRNA inhibitors can be significantly improved by the exclusive targeting of accessible HIV-1 RNA domains as determined by SHAPE technology.[@R12]

The new structure model of the HIV-1 RNA genome revealed many local folds like stem-loop or hairpin motifs that may play a distinct role in the virus replication cycle. Several well-known and important RNA structures were confirmed, such as the TAR hairpin and the RRE domain that serve as binding sites for the essential HIV-1 regulatory proteins Tat and Rev, respectively. The TAR hairpin is present at the extreme 5′ end of all HIV-1 transcripts and facilitates binding of Tat and host cell co-factors to stimulate transcription from the LTR promoter.[@R13]^-^[@R16] The RRE structure binds Rev to support the nuclear export of unspliced transcripts.[@R17] Other RNA structures were also confirmed, including the hairpin of the translational frameshift signal that facilitates Pol translation[@R18]^,^[@R19] and hairpins that regulate the accessibility of polyadenylation[@R20] and splicing signals.[@R21] Other RNA motifs that cluster in the 5′ untranslated region (5′ UTR) have been implicated in dimerization and packaging of the RNA genome in virion particles and the subsequent process of reverse transcription.[@R21]^-^[@R31] In addition, several long-distance base pairing interactions have been proposed.[@R32]^-^[@R34]

The SHAPE-derived HIV-1 RNA structure model revealed a multitude of novel structures that may play a role in virus replication. For instance, HIV-1 genomic RNA structures were recently proposed to orchestrate virus recombination events.[@R35] In this study, we set out to test the functional significance of some individual small hairpin RNA structures.

Results
=======

Phylogenetic analysis of structured RNA motifs
----------------------------------------------

We selected 16 candidate hairpin motifs across the SHAPE-derived RNA secondary structure model of the genome of the HIV-1 NL4-3 isolate for initial inspection (motifs A through P in [Fig. 1](#F1){ref-type="fig"}).[@R2] RNA structures that play important biological functions usually demonstrate robust structural conservation despite the presence of sequence variation in diverse virus isolates.[@R2]^,^[@R15]^,^[@R36]^-^[@R38] The best example of such structural conservation is the occurrence of base pair co-variations, e.g., A-U converted into G-C in another virus isolate. We therefore set out to focus on phylogenetically conserved RNA motifs as the most likely candidates to fulfill an important function in HIV-1 biology.

![**Figure 1.** Position of the 16 structured RNA motifs in the HIV-1 genome. (**A**) Motifs A through P on the HIV-1 DNA map. (**B**) SHAPE-derived model of the HIV-1 RNA secondary structure.[@R2] The 16 RNA motifs are marked.](rna-10-540-g1){#F1}

We analyzed the folding of the proposed hairpins with 5′ and 3′ flanks of maximal 5 nts in diverse HIV-1 isolates for which the full-length genome sequence is known. Isolates belonging to the major HIV-1 subtypes A, B, C and D, for which multiple full-length genome sequences are available, were aligned with the QuickAlign Analysis Tool ([www.hiv.lanl.gov/](http://www.hiv.lanl.gov/)) (July 2010). For each of the 16 hairpin fragments, we selected the most prevalent sequence per subtype as the prototype sequence. For example, we picked a subtype B sequence for hairpin H that occurs in 59 out of 235 sequences ([Table 1](#T1){ref-type="table"}, fourth column). The 64 prototype sequences were subsequently probed by the mfold program to allow the large scale analyses of predicted RNA secondary structures ([Fig. 2](#F2){ref-type="fig"}). First, we analyzed the mfold prediction for the HIV-1 subtype B NL4-3 isolate that was used to generate the SHAPE-directed RNA structure model. Only 10 of the 16 hairpins are predicted to fold according to the SHAPE model, consistent with the observation that inclusion of experimental data tends to yield significantly different structures than those predicted by mfold-type algorithms alone (listed in [Table 1](#T1){ref-type="table"}, last column as "+" for SHAPE-like or "-" for non-SHAPE with the thermodynamic stability in kcal/mol). When a non-SHAPE structure was predicted, the SHAPE-structure was sometimes seen as sub-optimal RNA fold, but frequently not predicted within the 5% energy window set by the mfold program.

###### **Table 1.** Phylogenetic analysis of 16 RNA structures in the HIV-1 genome

  ---------------------------------------------------------------------------------------------------------------------------------------
  name             position^a^   subtype         Prototype sequence^b^   nt differences^c^   RNA structure          
  ---------------- ------------- --------------- ----------------------- ------------------- ---------------------- ---------------------
                                                                                             **ΔG (kcal/mol)^d^**   **Conservation^e^**

  A                1076--1142    NL4--3                                                      -22.9                  \+

  gag, p24         A             2/6 (33%)       4                       -22.9               \+                     

                   B             23/235 (10%)    1                       -22.9               \+                     

                   C             12/397 (3%)     9                       -16.1               \-                     

                   D             6/49 (12%)      4                       -21.3               \+                     

  B                1459--1522    NL4--3                                                      -12.5                  \-

  gag, p2          A             1/6 (17%)       13 (3 del)              -8.0                \-                     

                   B             7/371 (2%)      2                       -15.0               \-                     

                   C             3/399 (1%)      23 (4 del)              -11.3               \-                     

                   D             2/51 (4%)       15                      -11.3               \-                     

  C                1823--1859    NL4--3                                                      -19.1                  \+

  gag, p6          A             2/6 (33%)       11                      -7.9                1/2B^f^                

  pol, prot        B             41/371 (11%)    2                       -18.1               \+                     

                   C             11/399 (3%)     10                      -17.1               \-                     

                   D             3/51 (6%)       5                       -17.5               \+                     

  D                2388--2484    NL4--3                                                      -23.1                  \-

  pol, RT          A             1/6 (17%)       10                      -34.1               \-                     

                   B             7/235 (3%)      2                       -21.7               \-                     

                   C             10/397 (3%)     8                       -27.5               \-                     

                   D             1/49 (2%)       6                       -21.4               \-                     

  E\               2619--2686    NL4--3                                                      -20.7                  \+
  POL1                                                                                                              

  pol, RT          A             1/6 (17%)       6                       -9.2                \+                     

                   B             39/235 (17%)    1                       -18.5               \+                     

                   C             26/397 (7%)     4                       -17.4               1/2B^f^                

                   D             6/49 (12%)      3                       -15.0               1/2B^f^                

                   CPZ           1/9 (9%)        26                      -12.4               \+                     

  F\               2781--2835    NL4--3                                                      -23.2                  \+
  POL2                                                                                                              

  pol, RT          A             2/6 (33%)       6                       -14.5               1/2A^f^                

                   B             53/235 (21%)    0                       -23.2               \+                     

                   C             122/397 (31%)   4                       -20.2               \+                     

                   D             8/49 (16%)      3                       -17.6               \+                     

                   CPZ           8/49 (16%)      3                       -17.6               \+                     

  G                3285--3358    NL4--3                                                      -23.4                  \-

  pol, RT          A             1/6 (17%)       8                       -25.2               \-                     

                   B             25/235 (11%)    1                       -23.9               \-                     

                   C             55/396 (14%)    5                       -22.5               1/2B^f^                

                   D             4/49 (8%)       3                       -23.9               \-                     

  H\               3606--3639    NL4--3                                                      -5.8                   \+
  POL3                                                                                                              

  pol, RNase H     A             1/6 (17%)       6                       -5.1                \+                     

                   B             59/235 (25%)    2                       -2.0                \+                     

                   C             140/395 (35%)   1                       -5.8                \+                     

                   D             17/49 (35%)     1                       -5.8                \+                     

                   CPZ           17/49 (35%)     1                       -5.8                \+                     

  I                5303--5343    NL4--3                                                      -12.3                  \-

  vpr              A             3/6 (50%)       5                       -3.9                \-                     

                   B             35/234 (15%)    1                       -9.8                \-                     

                   C             78/397 (20%)    6                       -4.5                \-                     

                   D             6/49 (12%)      3                       -4.5                \-                     

  J                5530--5581    NL4--3                                                      -12.4                  \+

  tat(1), rev(1)   A             1/6 (17%)       14                      -14.7               \-                     

                   B             6/371 (2%)      4                       -10.1               \-                     

                   C             17/399 (4%)     12                      -14.9               \-                     

                   D             2/51 (4%)       11                      -6.9                \-                     

  K                5600--5645    NL4--3                                                      -7.6                   \-

                   A             1/6 (17%)       21                      -6.5                \-                     

                   B             2/235 (1%)      7                       -8.8                \-                     

                   C             3/397 (1%)      30                      -0.4                \-                     

                   D             2/49 (4%)       8                       -8.8                \-                     

  L                6536--6598    NL4--3                                                      -17.8                  \-

  env, gp120       A             1/6 (17%)       11                      -10.3               \-                     

                   B             6/371 (2%)      4                       -8.8                \-                     

                   C             5/398 (1%)      13                      -8.4                \-                     

                   D             2/51 (4%)       9                       -11.6               \-                     

  M                6982--7016    NL4--3                                                      -7.9                   \+

  env, gp120       A             1/6 (17%)       17                      -1.3                \-                     

                   B             1/235 (\< 1%)   14                      0.7                 \-                     

                   C             1/397 (\< 1%)   17 (7 del)              -0.6                \-                     

                   D             1/49 (2%)       13                      -1.7                \-                     

  N                8455--8505    NL4--3                                                      -18.3                  \+

  nef, LTR         A             1/6 (17%)       11                      -11.8               \-                     

                   B             24/370 (7%)     partial del             -1.6                \-                     

                   C             8/399 (2%)      13                      -15.0               \+                     

                   D             4/51 (8%)       7                       -13.4               \-                     

  O\               8723--8773    NL4--3                                                      -26.6                  \+
  NEF1                                                                                                              

  nef, LTR         A             1/6 (17%)       8                       -13.3               1/2B^f^                

                   B             16/219 (7%)     2                       -19.0               \+                     

                   C             49/396 (12%)    4                       -25.1               \+                     

                   D             9/48 (19%)      4                       -19.6               \+                     

                   CPZ           1/11 (9%)       10                      -17.5               \+                     

  P                8867--8906    NL4--3                                                      -19.5                  \+

  nef, LTR         A             3/6 (50%)       13                      -11.0               \+                     

                   B             15/59 (25%)     6                       -7.1                \+                     

                   C             2/25 (8%)       14                      -6.0                \-                     

                   D             1/4 (25%)       11                      -3.9                \-                     
  ---------------------------------------------------------------------------------------------------------------------------------------

a\) NL4-3 coordinates

b\) Number of virus isolates that match the exact prototype sequence, which was identified by PrimAlign (Los Alamos HIV database)

c\) Compared with NL4-3

d\) Calculated by mfold for the prototype sequence

e\) Structural similarity between SHAPE model[@R2] and predicted mfold structure; structure maintained = +; structure changed = -

f\) 1/2A = only first domain maintained, 1/2B = only second domain maintained.

![**Figure 2.** Probing RNA structure conservation among the subtypes. The original SHAPE-directed model (left) is compared with the mfold prediction for the subtype B isolate NL4-3 and the prototype sequence of subtypes A, B, C and D. Sequence differences compared with the NL4-3 sequence are highlighted in black. Structural conservation is illustrated for POL3, partial conservation for motif M and a lack of conservation for motif B. See [Table 1](#T1){ref-type="table"} for more details. Single-stranded RNA segments that lack mutations compared with the NL4-3 sequence are indicated as N~x~, with x indicating the number of nucleotides.](rna-10-540-g2){#F2}

Mfold analyses of the 16 hairpin segments among the 4 HIV-1 subtypes provided a wide range of results. Some SHAPE-like hairpins were recapitulated by mfold, not only for subtype B but for all four subtypes ([Table 1](#T1){ref-type="table"}, motifs E, F, H and O). For example, we show the predicted structure for motif H ([Fig. 2A](#F2){ref-type="fig"}). [Figure 2B and C](#F2){ref-type="fig"} show some of the 14 structured motifs (M and B, respectively) that are not supported by this phylogenetic survey (marked in gray in [Table 1](#T1){ref-type="table"}) and that will be discussed below. The structural conservation of the motifs E, F, H and O is remarkable because there is considerable sequence variation among the isolates and especially the subtypes. For instance, we scored 4‒8 nt changes in motif O in the non-B subtypes compared with the NL4-3 strain ([Table 1](#T1){ref-type="table"}, motif O). This provides some phylogenetic support for structural conservation, which hints at a biological function of the candidate RNA structures. On the other hand, it is clear that the new candidate hairpins are not as stable stem-loop structures as the well-known TAR and RRE motifs. Based on these results, we selected the most promising small hairpin motifs---E, F, H and O---for further functional analysis. Although we assume that these relatively small RNA hairpins were conserved during HIV-1 evolution and diversification, thus suggesting a role in HIV-1 biology, it cannot formally be excluded that they arose by convergent evolution. These four structures were renamed POL1, POL2, POL3 and NEF1, respectively, according to their position in the HIV-1 genome ([Fig. 1A](#F1){ref-type="fig"}). POL3 is a small hairpin and the other motifs represent tandem hairpin structures with two subdomains, termed A and B. We also probed these four structures in the more divergent simian immunodeficiency virus chimpanzee isolate (SIV-cpz), which confirmed the SHAPE-like folding ([Table 1](#T1){ref-type="table"}).

All other 12 hairpin candidates were dismissed because no SHAPE-like structure was consistently predicted by mfold (marked in gray in [Table 1](#T1){ref-type="table"}). For five hairpin motifs, none of the prototype sequences of different HIV-1 subtypes adopt the SHAPE-proposed folding as the most favorite RNA conformation ([Table 1](#T1){ref-type="table"}, motifs B, D, I, K, L). For example, a wide range of structural presentations are apparent for motif B ([Fig. 2C](#F2){ref-type="fig"}). For seven hairpin motifs, an intermediate result was obtained, i.e., prediction of a non-SHAPE structure for at least one subtype ([Table 1](#T1){ref-type="table"}, motifs A, C, G, J, M, N and P). For instance, motif M adopts SHAPE-like structures only for the NL4-3 isolate ([Fig. 2B](#F2){ref-type="fig"}). We realize that this in silico mfold analysis is certainly not appropriate to formally rule out some of the predicted hairpin motifs. This information was however used to select the SHAPE-determined RNA structures that have the strongest phylogenetic support.

As a next test for the four conserved hairpins that were selected, we probed the sequence variation in all virus isolates for the presence of base pair co-variations that could provide phylogenetic support for the proposed base pairing schemes. We used the sequence information present in the HIV-1 2010 compendium (subtype A with 16 isolates, B = 34, C = 21, D = 11 and SIV-cpz = 5).[@R39] We checked whether the available sequence variation does maintain or destabilize the proposed hairpin structure. We first performed this phylogenetic analysis within each subtype. [Figure 3](#F3){ref-type="fig"} illustrates this analysis for subtype B for the four structures POL1, POL2, POL3 and NEF1. Analyses of all inspected subtypes A, B, C, D and SIV-cpz are presented in the [**Figure S1**](#SUP){ref-type="supplementary-material"}. Of special interest are structure-conservative mutations on one strand (e.g., G-U to G-C, marked blue in [Fig. 3](#F3){ref-type="fig"}) or on both strands of the base paired stem (e.g., A-U to G-C co-variation, marked red in [Fig. 3](#F3){ref-type="fig"}). We identified several structure-conservative mutations in these RNA structures and co-variations were detected in the POL1 and NEF1 hairpins ([Fig. 3](#F3){ref-type="fig"}). In total, the four SHAPE-identified hairpin motifs POL1, POL2, POL3 and NEF1 harbor a fair degree of structural conservation, although much more extensive phylogenetic evidence was previously reported for TAR hairpin.[@R15]

![**Figure 3.** The impact of natural sequence variation on the POL1, POL2, POL3 and NEF1 structures for subtype B sequences derived from the HIV-1 compedium 2010. The majority sequence is depicted for each subtype with variations in small circles with a number that refers to the particular isolate. Blue circles mark changes that conserve the structure, red circles represent base pair co-variation. Isolate code: Number = isolate name: 1 = B.AR.04.04AR143170; 2 = B.AU.04.PS1038_Day174; 3 = B.BO.99.BOL0122; 4 = B.BR.05.BREPM1081; 5 = B.CA.97.CANB3FULL; 6 = B.CN.05.05CNHB_hp3; 7 = B.CO.01.PCM001; 8 = B.CU.99.Cu19; 9 = B.CY.06.CY165; 10 = B.DE.86.D31; 11 = B.DK.04.PMVL_012; 12 = B.DO.05.05DO_160884; 13 = B.EC.89.EC003; 14 = B.ES.07.X2231; 15 = B.FR.92.92FR_BX08; 16 = B.GA.88.OYI; 17 = B.GB.86.GB8_46R; 18 = B.GE.03.03GEMZ004; 19 = B.HT.05.05HT_129389; 20 = B.IN.x.11807; 21 = B.JM.05.05JM_KJ108; 22 = B.JP.05.DR6538; 23 = B.KR.04.04KMH5; 24 = B.MM.99.mSTD101; 25 = B.NL.00.671_00T36; 26 = B.RU.04.04RU128005; 27 = B.TH.00.00TH_C3198; 28 = B.TT.01.01TT_CRC50069; 29 = B.TW.94.TWCYS; 30 = B.UA.01.01UAKV167; 31 = B.US.07.CR0027M; 32 = B.UY.01.01UYTRA1179; 33 = B.YE.02.02YE507; 34 = B.ZA.03.03ZAPS045MB2.](rna-10-540-g3){#F3}

Mutational disruption of selected hairpin motifs
------------------------------------------------

To investigate the biological relevance of the four selected hairpin motifs, we destabilized the individual hairpins by introducing mutations in the genome of the primary CXCR4 using HIV-1 LAI isolate. We designed silent codon changes in the underlying pol and nef genes to exclude adverse effects due to amino acid substitutions in the encoded proteins. Additionally, we ensured that the introduced mutations did not modify known RNA signals such as splice donor/acceptor sites. For motifs POL1, POL2 and NEF1 that consist of two hairpin domains, we chose to destabilize the stem region that contributes most to the stability of the motif, as determined by mfold analyses (results not shown). All possible silent codon changes were analyzed using mfold to determine which ones were most disruptive to the RNA structure. We designed two to six mutations per motif to trigger the formation of an alternative, less stable RNA fold ([Fig. 4](#F4){ref-type="fig"}). In addition, we made several combination mutants: Double (POL1+POL3), Triple (POL1-3) and Quadruple (POL1-3, NEF1).

![**Figure 4.** Mutational disruption of the POL1, POL2, POL3 and NEF1 structures. We marked the nts that were altered in wt (left) to create the mutant (right) structures. For POL1, POL2 and NEF1 we changed a single stem domain.](rna-10-540-g4){#F4}

We first tested the wild-type (wt) and mutant HIV-1 LAI-based DNA constructs for their ability to produce viral proteins. 293T cells were transfected and CA-p24 production was measured in the culture medium after 2 d. All mutants, including the combination mutants, exhibited similar CA-p24 production as the wt construct ([Fig. 5A](#F5){ref-type="fig"}). These results imply that the RNA mutations do not have a significant impact on HIV-1 gene expression, including the processes of transcription, splicing and translation, but also mRNA stability.

![**Figure 5.** Phenotype tests of the wt and mutant pLAI constructs. (**A**) CA-p24 production in 293T cells transfected with pLAI variants. (**B**) LTR-luc constructs for wt and Nef1 were tested for promoter activity in transfected 293T cells. (**C**) Virus replication in SupT1 T cells monitored by CA-p24 production. Cells were transfected with the indicated constructs at day 0 (x-axis: days post-transfection). (**D**) Virus replication in PBMCs monitored by CA-p24 production. Cells were infected with the indicated HIV-1 variants at day 0 (x-axis: days post-infection) (left: 0.1 ng CA-p24, right: 1 ng CA-p24).](rna-10-540-g5){#F5}

It is important to discuss the NEF1 mutant in more detail. The NEF1 hairpin is located within the nef gene, more particular in the U3 region encoded by the 3′LTR. We introduced the NEF1 mutation in the 3′LTR of the LAI molecular clone, but these U3 sequences are copied into the 5′LTR during reverse transcription. Thus, the viral progeny will carry this mutation in the 3′ end of the HIV-1 RNA genome and in the 5′LTR that serves as the transcriptional promoter. The latter modification may also have an impact on virus replication. To test for such a transcriptional effect, we made LTR-luciferase constructs with the wt and Nef1 mutant sequences. These constructs were transfected into 293T cells without or with an increasing amount of pTat expression plasmid. We measured no differences in luciferase expression level between the wt and Nef1 constructs, both in basal activity and Tat-induced expression ([Fig. 5B](#F5){ref-type="fig"}). Thus, the U3 changes introduced in the Nef1 mutant do not adversely affect LTR promoter activity.

We next performed replication studies with the wt and mutant HIV-1 viruses on the CXCR4-expressing SupT1 T cell line that supports efficient replication of the LAI strain. We first infected SupT1 T cells with equal amounts of virus (based on CA-p24) that was produced in 293T cells. The cell cultures were monitored on a daily basis to score HIV-1 induced cytopathic effects and cell culture supernatants were regularly collected to quantify the accumulation of CA-p24 as a sign of virus replication. We did not observe significant differences in replication capacity between the wt and mutant viruses ([Fig. 5C](#F5){ref-type="fig"}). Similar results were obtained in replication assays that were started by electroporation of the viral DNA constructs into SupT1 cells (results not shown). We next tested virus replication on peripheral blood mononuclear cells (PBMCs) because some defects, e.g., the Nef protein minus phenotype, become apparent only in primary cells and not in transformed T cell lines.[@R40] We pooled PBMCs of four healthy donors and infected them with the wt and mutant HIV-1 variants. Again, all HIV-1 mutants including the combination mutants replicated as efficiently as wt virus ([Fig. 5D](#F5){ref-type="fig"}).

We finally applied the ultra-sensitive virus competition assay to document whether the mutants are truly equal in replication capacity to the wt virus. This method of direct virus competition was specifically designed to reveal very subtle differences in virus replication rates.[@R41] We made an equimolar mixture of two HIV-1 plasmids (wt and mutant) and transfected SupT1 cells via electroporation to start the competitive virus infections. We took cell samples at several time intervals (2, 3, 5 and 8 wk post-transfection) and analyzed the proviral DNA sequences as a measure of the wt:mutant ratio in order to observe outgrowth of the fittest virus. To do so, we isolated the proviral DNA and sequenced the relevant DNA segments. The input virus population was visible as a mixed population sequence, but this will change over time once the fittest virus becomes the dominant species. We detected only insignificant replication defects for some of the mutants upon extended culturing (results not shown). Thus, these mutations have no or only a negligible impact on HIV-1 replication in vitro.

Discussion
==========

The SHAPE-determined structure of the complete 9 kb HIV-1 RNA genome does reveal an intense collection of structured RNA elements, mostly local hairpin structures.[@R2] Other studies revealed additional long-range RNA interactions.[@R32]^,^[@R33] This may suggest an important role for the genome-wide HIV-1 RNA structure in virus replication, which could include protection against RNases and modulation of the innate immune responses. We set out to experimentally probe the importance of several small RNA motifs across the viral genome. A total of 16 hairpin motifs were examined in silico for conservation among different HIV-1 isolates and subtypes, and we selected the four most promising hairpin motifs for experimental validation. We were not able to score a significant replication deficit of these mutants, even in primary T cells and in ultra-sensitive virus competition assays. We nevertheless believe that the presence of many structured RNA motifs in the HIV-1 RNA genome does likely reflect the presence of a minor evolutionary pressure that shaped the viral genome over extended times, but many of these structured motifs may not have a direct and critical replicative function. This result does obviously not exclude an important function for other SHAPE-determined RNA-structures in HIV-1 biology. These results would argue against the notion that the HIV-1 retrovirus belongs to the group of RNA viruses with a global genome-wide RNA conformation (GORS).

The RNA genome of several but not all RNA viruses is highly structured. One of the most intensively studied examples is the RNA genome of *Escherichia coli* RNA phages MS2 and Qβ. This RNA is highly structured with 75% of the nts estimated to take part in base pairing. Detailed RNA structure models have been built based on enzymatic and chemical sensitivity of nts, phylogenetic sequence comparison and the phenotypes of constructed mutants.[@R42]^,^[@R43] The RNA folds into an array of mostly irregular helices and is further condensed by several long-distance interactions. Substantial conservation of these helices between the related coliphages attests to the relevance of discrete RNA folding. Certain structured RNA motifs fulfill important roles in virus replication, e.g., as protein binding site or to regulate translation and replication.[@R44]^,^[@R45] This genome-wide secondary structure is thought to prevent permanent annealing of the plus and minus strand RNA strands during virus replication and/or to confer protection against RNases. Unlike positive-stranded RNA viruses, HIV-1 is not likely to require RNA structure to prevent permanent annealing of plus and minus strands during virus replication because retroviruses replicate through an RNA-DNA intermediate, of which the RNA strand is actively removed by RNase H activity of the elongating reverse transcriptase enzyme. The minus strand DNA is subsequently copied into double-stranded DNA that integrates into the host cell genome.

RNA structures also play a crucial role in the innate defense mechanism that protects cells against invading viral pathogens. Viral infection results in the generation of non-self RNA species in the cell, which are recognized by retinoic acid inducible gene-I-like receptors (RLRs) to initiate innate antiviral responses, including the production of proinflammatory cytokines and type I interferon.[@R46] Much research is ongoing to specify the non-self RNA patterns that are recognized by the defense machinery of the host cell. The double-stranded nature of the genome of eukaryotic viruses does relate to the presence of innate defense mechanisms of the host cell. Viral RNA genomes may use the extensive double-stranded character for interaction with a family of structurally related dsRNA-binding proteins (DRBPs) that are coupled to a wide range of antiviral effector pathways.[@R47]^-^[@R49] The dsRNA-dependent protein kinase (PKR) induces apoptosis and modulates the interferon response pathways, and activation of oligoadenylate synthetase results in RNase L production and cytoplasmic RNA cleavage.[@R50] Dicer-mediated cleavage of dsRNA produces small interfering RNAs (siRNA) that target complementary RNA sequences for destruction by the RNA-induced silencing complex (RISC) of the RNAi mechanism, although this option does not hold for retroviruses like HIV-1 that lack a dsRNA replication intermediate. Furthermore, viral RNA genomes may encode hairpin motifs that resemble microRNA (miRNA) precursors, which are cleaved by the Drosha endonuclease. Such antiviral siRNAs and miRNAs have recently also been detected in HIV-infected cells.[@R51]^-^[@R54]

The ability of HIV-1 to persist in the host may relate to its ability to circumvent these innate defense systems by having a highly structured RNA genome. Using bioinformatics, GORS were identified in several positive-strand animal and plant RNA viruses.[@R6] Using atomic force microscopy, hepatitis C virus RNA was visualized as tightly compacted spheroids, while under the same experimental conditions the predicted unstructured poliovirus and rubella virus RNA were pleomorphic with an extensive single-stranded signature.[@R7] There was remarkable variability between the virus genera that possess this characteristic; e.g., some viruses show evidence for extensive base pairing throughout the protein-coding sequences that was absent in other viruses. The presence of a GORS-like RNA genome seems to correlate with the capacity of the corresponding viruses to cause a persistent infection in their natural hosts.[@R6] This raises the intriguing possibility of a role for GORS in the modulation of innate intracellular defense mechanisms triggered by double-stranded RNA.[@R55]^,^[@R56] Our in vitro virus replication studies may not be appropriate to test for such effects. The study by Simmonds et al. also revealed that persistent and non-persistent viruses differ in the extent of their dinucleotide frequency biases.[@R6] In this respect, the HIV-1 RNA genome has a highly biased composition with up to 40% A nts.[@R57]^,^[@R58] It is likely that both sequence and structure elements of the viral RNA genome control the functional interactions with the host cell.

Materials and Methods
=====================

In silico analysis
------------------

Sixteen RNA structures in the SHAPE-derived HIV-1 RNA model were selected for this study.[@R2] To determine phylogenetic conservation of RNA structure motifs, the four prototype sequences representing the four dominant HIV-1 subtypes (A, B, C and D, and in some cases also SIV-chimpanzee sequences) were determined with the QuickAlign Analysis Tool (Los Alamos HIV database, July 2010). The prototype sequences were used to perform mfold RNA structure prediction using standard settings.[@R59] Four RNA motifs revealed high structural conservation despite sequence variation. The sequence variation in natural HIV-1 isolates is shown in [**Figure S1**](#SUP){ref-type="supplementary-material"} (number of sequences per subtype: A = 16, B = 34, C = 21, D = 11 and SIV-cpz = 5).

HIV-1 DNA constructs
--------------------

To investigate the potential biological function of the 4 selected RNA motifs, silent mutations were introduced into the subtype B molecular clone pLAI with oligonucleotides ([Table 2](#T2){ref-type="table"}). We used mfold to determine which silent codon mutations have the greatest structural impact. For mutants POL1, POL2 and POL3, the QuikChange Site-Directed Mutagenesis kit (Stratagene) was used following the manufacturer's instructions including the Pfu Turbo DNA polymerase. For mutant NEF1, a 2-step PCR method was applied using the Phusion High Fidelity DNA polymerase (Finnzymes) as this sequence appears twice in pLAI in the 5′- and 3′LTR sequences. The NEF1-PCR fragment was subsequently cloned into the 3′LTR pLAI via the restriction sites Aat2 and BamH1. During HIV-1 replication, the Nef1 mutation in the 3′LTR will be copied in the 5′LTR promoter during the process of reverse transcription. To test for an effect on promoter activity, the LTR was fused to the firefly luciferase gene in pLTR-luc plasmid.[@R60] The Nef1 mutations were introduced to generate the pLTR-Nef1 luciferase construct using the QuikChange Site-Directed Mutagenesis kit. All mutations were confirmed via sequencing.

###### **Table 2.** Oligonucleotides used for mutagenesis, PCR amplification and sequencing

  Name          Position^a^   Sequence^b^
  ------------- ------------- ----------------------------------------------------------------
  POL1 fw       2651--2696    CAAAATCCAGACAT**T**GT**A**AT**A**TA**C**CAATACATGGATGATTTGTATG
  POL1 rev                    CATACAAATCATCCATGTATTG**G**TA**T**AT**T**AC**A**ATGTCTGGATTTTG
  POL2 fw       2816--2858    GGATGGGTTATGAACT**A**CA**C**CCTGATAAATGGACAGTACAGCC
  POL2 rev                    GGCTGTACTGTCCATTTATCAGG**G**TG**T**AGTTCATAACCCATCC
  POL3 fw       3650--3696    CAAGCACAACCAGATAAA**TCA**GAA**AGC**GAGTTAGTCAATCAAATAAT
  POL3 rev                    ATTATTTGATTGACTAACTC**GCT**TTC**TGA**TTTATCTGGTTGTGCTTG
  NEF1 fw       8803--8846    CTTTGGATGGTGCTACAAGCT**T**GT**C**CC**C**GTTGAGCCAGATAAGG
  NEF1 rev                    CCTTATCTGGCTCAAC**G**GG**G**AC**A**AGCTTGTAGCACCATCCAAAG
  FGSA-32-Fb    2289--2308    AAATCC ATACAATACTCCAG
  TA051         3471--3488    CAGGGAGACTAAATTAGG
  RT-Pfo-as     3973--3997    GTTGCCATATTCCTGGACTACAGTC
  5′NEF-1       8277--8300    GCAGTAGCTGAGGGGACAGATAGG
  5′NEF-LTR01   8612--8633    CTTTAAGACCAATGACTTACAA
  tTA-rev1-AD   8925--8946    GTCAAACCTCCACTCTAACACT

a\) HIV LAI

b\) Silent mutations marked.

Mutations were combined as follows: pLAI-POL1 was used for a second round of site-directed mutagenesis using oligonucleotides POL3 fw and rev to create the double mutant, which was used to create the triple mutant with the POL2 oligonucleotides. Finally, the region encompassing the NEF1 motif was cloned into the triple pLAI mutant via the restriction sites Aat2 and BamH1 to make the quadruple mutant.

Cell culture
------------

293T cells were maintained in Dulbecco's modified Eagle's medium (DMEM, Invitrogen) with 100 U/ml penicillin, 100 µg/ml streptomycin, 10% fetal calf serum (FCS, Hydrobond) and minimal essential medium nonessential amino acids (DMEM/10% FCS). The SupT1 cell line was maintained in Advanced RPMI (Gibco) supplemented with L-glutamine, 1% FCS, 30 U/ml penicillin and 30 µg/ml streptomycin. PBMCs were obtained from fresh buffy coats (Central Laboratory Blood Bank) of different HIV-1 negative donors using Ficoll-Hypaque gradient. Cells of four donors were pooled and stored at -150°C. One week prior to infection, cells were thawed, and stimulated for 2 d with phytohemagglutinin (PHA, 4 µg/ml) and Interleukin-2 (IL-2, 100 U/ml) as described previously.[@R61] PBMCs were cultured in RPMI medium supplemented with 10% FCS, IL-2 and without antibiotics. All cells were kept at 37°C and 5% CO~2~.

Luciferase assay
----------------

293T cells were seeded one day prior to transfection in the 24-well plate format. Eighty ng of pLTR-luc or pLTR-NEF1-luc were mixed with 0--50 ng of pTat to activate the LTR promoter. pBluescript was added to 250 ng of total DNA amount. Transfection was performed with Lipofectamine 2000 following the manufacturer's instructions. Cells were lysed 48 h post-transfections with 150 µl of Passive Lysis Buffer (Promega) and Firefly expression was measured as described previously.[@R62]

HIV-1 production, virus replication and virus competition studies
-----------------------------------------------------------------

Virus production was measured in 293T cells that were seeded in the 24-well plate format and transfected with 200 ng of the pLAI variants with the Lipofectamine 2000 protocol. Culture supernatants were collected after 48 h and virus production was scored by CA-p24 ELISA. These experiments were conducted in duplicate or triplicate and performed on three occasions. Variation between the three independent experiments was corrected using the factor correction program.[@R63]

HIV-1 virus stocks were produced on 293T cells, which were seeded in a 6-well plate format one day prior to transfection. Four µg of wt or mutant pLAI was transfected following the Lipofectamine 2000 protocol and the supernatant was harvested at 48 h post transfection. Cells were removed by centrifugation (4,000 × g) and the supernatant was aliquoted and stored at -80°C. Virus production was quantified by CA-p24 ELISA. HIV-1 (0.001 ng of CA-p24) was used to infect 200,000 SupT1 cells in the 24-well plate format, with three or six parallel cultures. PBMC infections were performed in quadruplicate in the 96-well plate format with 200,000 PBMCs and HIV-1 (0.1--1 ng CA-p24)-. Supernatants of the SupT1 and PBMC cultures were collected three times a week to measure CA-p24, and cultures were monitored for cytopathic effects using light microscopy.

Virus competition studies were performed to detect subtle replication differences. One hundred and fifty ng of the mutant plasmids (Pol1, Pol2, Pol3, Nef1, double, triple and quadruple) were individually mixed with an equal amount (150 ng) of wt pLAI. Input plasmid mixtures were sequenced to verify the equimolar input, which is displayed by a mixed sequence with equally high peaks. SupT1 cells were transfected with this equimolar plasmid mixture via electroporation (250V, 975 µF) using the Bio-Rad Gene Pulser II.[@R21] Cells were split once or twice a week and cell-free virus was passaged onto fresh SupT1 cells when massive virus-induced cytopathic effects were detected for up to 8 wk.[@R21]^,^[@R64] This was performed in three parallel cultures. The dominant variant in each culture was determined by isolation of the total cellular DNA, PCR amplification of the mutated region in integrated HIV-1 proviruses and determination of the population sequence. Total cellular DNA was isolated using proteinase K treatment as previously described,[@R65] and the regions encompassing the altered motifs were PCR amplified and sequenced. For POL1, POL2 and POL3, oligonucleotides FGSA-32-Fb and RT-Pfo-as were used to amplify a 1.7 kb Pol fragment. For NEF1, primers 5′NEF-1 and tTA-rev1-AD amplified the respective part of the nef/U3 region. The quality of PCR products was checked on agarose gel. Motifs POL1 and POL2 were subsequently sequenced with FGSA-32-Fb, POL3 with TA051 and NEF1 with 5′NEF-LTR01. All oligonucleotides are listed in [Table 2](#T2){ref-type="table"}.

Supplementary Material
======================

###### 

Click here for additional data file.
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